IHH unit Northern TK Venture appealed a Tokyo court's Sept. 10, 2026 dismissal of its up-to-$1.1 billion damages claim against Daiichi Sankyo over Fortis delays.

Business· Sep 24, 2026

Facts from Wikidata (CC0). Image by Daiichi Sankyo Company, Limited via Wikimedia Commons (CC BY 2.5).

Daiichi Sankyo

Japanese pharmaceutical company

0members1here now

Ask Genius Site

Site Journal

Feed Discussions About

Sort by

Content type

Latest Daiichi Sankyo news and discussion

Sort by

Content type

Daiichi Sankyo· Business · 7 sources · Sep 24, 2026Story

IHH Unit Appeals Tokyo Court Dismissal of $1.1B Daiichi Sankyo Claim

IHH unit Northern TK Venture appealed a Tokyo court's Sept. 10, 2026 dismissal of its up-to-$1.1 billion damages claim against Daiichi Sankyo over Fortis delays.

Business· Sep 24, 2026

Facts from Wikidata (CC0). Image by Daiichi Sankyo Company, Limited via Wikimedia Commons (CC BY 2.5).

Daiichi Sankyo across IJR

Ask Genius by OpenServe about Daiichi Sankyo Create in Studio Build a game Watch videos

About Daiichi Sankyo

Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.

members

here now

Country: Japan
Headquarters: Chūō
Inception: 2005
Website: https://www.daiichisankyo.co.jp/

Coverage spread L26 / C32 / R42

Everything about Daiichi Sankyo →

Related journals

Connected

Japan Pharmaceutical Manufacturers Association Japan

Live room · 1 here

Be the first in the room — members see you arrive.

Join the room

Related journals

Connected

Japan Pharmaceutical Manufacturers Association Japan

Daiichi Sankyo across IJR

Ask Genius by OpenServe about Daiichi Sankyo Create in Studio Build a game Watch videos